Relative Bioavailability and Food Effect of SYHA1813 Oral Solution in Healthy Participants

NCT06157918 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: SYHA1813 oral solution (2.0g:25mg)
DRUG: SYHA1813 oral solution (20ml:200mg)

Sponsor

Shanghai Runshi Pharmaceutical Technology Co., Ltd